Skip to content

A study of STX-721/PFL-721 in participants with non-small cell lung cancer with certain mutations

Status
Recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-506759-51-00
Acronym
PFL721CI101
Enrollment
128
Registered
2024-02-19
Start date
2024-03-29
Completion date
Unknown
Last updated
2025-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Interventions

None listed

Sponsors

Pierre Fabre Medicament
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

France, Germany, Netherlands, Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026